Cogent Biosciences, Inc. COGT
28.97 USD -0.43 (-1.46%)
Nov 12, 2026, 9:30 AM EST
28.85 Day range 29.24
27.74 52-week range 43.73
- YTD
- -18.44%
- 1 year
- -13.32%
News
benzinga.com HC Wainwright & Co. Maintains Buy on Cogent Biosciences, Raises Price Target to $56 HC Wainwright & Co. analyst Robert Burns maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $55 to $56.
benzinga.com If You Invested $1000 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Today Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 19.53% on an annualized basis producing an average annual return of 30.65%. Currently, Cogent Biosciences has a…- benzinga.com Here’s How Much You Would Have Made Owning Cogent Biosciences Stock In The Last 5 Years Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 14.59% on an annualized basis producing an average annual return of 26.37%. Currently, Cogent Biosciences has a…
benzinga.com $1000 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 16.44% on an annualized basis producing an average annual return of 28.63%. Currently, Cogent Biosciences has a…- benzinga.com Here’s How Much You Would Have Made Owning Cogent Biosciences Stock In The Last 5 Years Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 18.64% on an annualized basis producing an average annual return of 30.55%. Currently, Cogent Biosciences has a…
benzinga.com Wedbush Reiterates Outperform on Cogent Biosciences, Maintains $55 Price Target Wedbush analyst David Nierengarten reiterates Cogent Biosciences (NASDAQ:COGT) with a Outperform and maintains $55 price target.
benzinga.com HC Wainwright & Co. Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target HC Wainwright & Co. analyst Robert Burns reiterates Cogent Biosciences (NASDAQ:COGT) with a Buy and maintains $55 price target.
benzinga.com FDA Accepts Cogent Biosciences' NDA For Bezuclastinib In Patients With Advanced Systemic Mastocytosis NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSMPDUFA target action date set for…
benzinga.com Cogent Biosciences Enters Commercial Supply Agreement With Hovione On Sept 1, 2026; To Purchase Minimum Percentages Of Bezuclastinib Products From Hovione; Agreement Effective For Five-Year Term With Automatic Two-Year Renewals On September 1, 2026, Cogent Biosciences, Inc. (the "Company") entered into a Commercial Supply Agreement (the "Agreement") with Hovione FarmaCiencia S.A. ("Hovione") to manufacture bezuclastinib- benzinga.com $100 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 22.44% on an annualized basis producing an average annual return of 33.55%. Currently, Cogent Biosciences has a…
benzinga.com Piper Sandler Maintains Overweight on Cogent Biosciences, Raises Price Target to $55 Piper Sandler analyst Christopher Raymond maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from $52 to $55.
benzinga.com Guggenheim Maintains Buy on Cogent Biosciences, Raises Price Target to $52 Guggenheim analyst Michael Schmidt maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $45 to $52.
benzinga.com Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Gold Jumps Over 2%; Dole Shares Gain After Q3 Results 
benzinga.com Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday 
benzinga.com Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday 
benzinga.com US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns' U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benchmark indices were trading mixed.
benzinga.com Dow Dips 1%; Mustang Bio Shares Spike Higher 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday 
benzinga.com Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 647 companies set new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
- benzinga.com This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday Gainers
- benzinga.com Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus…
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 454 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 216 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's morning session, 88 stocks hit new 52-week lows.
- benzinga.com What's Hot On TheStreet